Oxford Instruments (LON:OXIG) published its full-year results announcement on 9 June with investors looking for confirmation that a difficult first half has given way to a stronger growth trajectory.
The scientific instrumentation specialist has spent the past year navigating tariff disruption, weaker academic spending and a slower demand environment in parts of its Imaging & Analysis division.
| Oxford Instruments (LON:OXIG) | Price: £28.80 (-6.7%) | Market cap: £1.48bn |
However, the more important story for long-term investors is the accelerating momentum within Advanced Technologies, particularly compound semiconductors and other high-growth industrial applications.
FY 2026 Snapshot
| Metric | FY2026 | FY2025* |
| Revenue | £423.2m | £443.4m |
| Adjusted operating profit | £73.7m | £79.5m |
| Adjusted operating margin | 17.4% | 17.9% |
| Order intake growth | ~8% | Positive |
| Book-to-bill ratio | ~1.06x | Above 1x |
*2025 FY restated
While headline profits have softened from last year’s record levels, management has successfully protected profitability during a cyclical slowdown and enters FY 2027 with improving order momentum.
Growth opportunity
The biggest attraction remains Oxford Instruments’ exposure to structural technology themes rather than traditional industrial demand.
Its Advanced Technologies division is benefiting from:
- Compound semiconductor investment.
- Datacentre and optical communications infrastructure.
- Advanced materials research.
- Semiconductor manufacturing equipment demand.
- Emerging quantum and photonics applications.
Particularly encouraging is management’s comment that the Advanced Technologies order book now extends beyond FY 2027 and into FY 2028. That level of visibility is unusual for a company of Oxford Instruments’ size and suggests customers remain committed to long-term investment programmes.
For retail investors, this matters because today’s orders become tomorrow’s revenues.
Raspberry Pi shares surge after update: Is this UK AI growth stock still a buy?
Capital returns remain attractive
Oxford Instruments has quietly become one of the more shareholder-friendly UK technology companies.
Following the sale of its NanoScience business in January 2026, management launched a £100 million capital return programme. A £50 million buyback tranche has already been completed, with a second tranche underway.
Buybacks at sensible valuations can enhance earnings per share growth and provide support during periods of market volatility.
Although the dividend yield remains modest compared with many FTSE income stocks, Oxford Instruments continues to grow its payout while retaining significant capital for investment.
Share price performance
The shares have delivered a volatile but ultimately rewarding journey for long-term investors. According to Morningstar data, the stock has delivered average total returns (share price + dividends) of ~17% a year over the past decade, close on double that of the FTSE 250 Index.
More recent performance has been less impressive. Following strong post-pandemic demand, the stock enjoyed a substantial re-rating as investors recognised its exposure to semiconductor and advanced technology markets. The shares then suffered during 2025 as tariffs, academic funding uncertainty and weaker order patterns created concerns over growth.
However, confidence returned during early 2026 as management demonstrated that order momentum was improving and that Advanced Technologies was delivering exceptionally strong demand growth.
| OXIG vs FTSE 250 | YTD | 1 year | 5 years | 10 years |
| OXIG | ~50.5% | ~72.1% | ~8.7% | ~16.8% |
| FTSE 250 | ~5.8% | ~20.1% | ~10.8% | ~8.7% |
Source: Morningstar. Average annual total return.
The result is a business that has experienced short-term earnings pressure while simultaneously strengthening its longer-term growth prospects.
Valuation
At ~£28.80, Oxford Instruments trades at a premium to many UK industrial businesses.
That premium is justified by:
- Strong intellectual property.
- High barriers to entry.
- Exposure to structural technology growth markets.
- Consistently high returns on capital.
- Attractive long-term margin potential.
The key question for investors is whether earnings growth reaccelerates sufficiently in FY 2027 and FY 2028.
If Advanced Technologies converts its growing order book into revenue as expected, today’s valuation appears reasonable rather than excessive. However, investors should recognise that much of the near-term recovery story is already reflected in the share price.
Investor verdict
Oxford Instruments is not a bargain stock, but quality rarely comes cheaply and the first half has given way to a stronger growth trajectory. The combination of improving order momentum, substantial exposure to semiconductor and photonics growth markets, ongoing share buybacks and strong returns on capital creates an attractive long-term investment case.
For investors willing to accept some cyclical volatility, Oxford Instruments remains one of the most compelling technology-enabled industrial growth stories on the UK market.
You might also like:
